A new Alzheimer’s drug. That has always been the dream.
Oklahoma City-County Health Department will use wastewater data in response planning.
OMRF scientists Tim Griffin and Albert Batushansky are pushing the bounds of a decades-old scientific method to study the origins of osteoarthritis.
OMRF researcher Courtney Griffin received a seven-year grant to pursue novel research into blood vessel function and factors that lead to uncontrolled bleeding.
OMRF has entered a license agreement with Shanghai RAAS Blood Products for development of novel hemophilia treatment.
This collaboration is part of GSK’s “Discovery Partnerships with Academia” (DPAc) efforts.